Signatures were evaluated in stratifying within each of luminal A (LumA, n = 310), luminal B (LumB, n = 209), HER2-enriched (Her2, n = 87) and basal (Basal, n = 113) subtype breast cancers. This evidence concerns the gene ERBB2 and breast carcinoma.